CV THERAPEUTICS INC
S-3, EX-23.1, 2000-07-19
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CV THERAPEUTICS INC, S-3, EX-5.1, 2000-07-19
Next: MORGAN STANLEY DEAN WITTER INTERNATIONAL SMALLCAP FUND, 24F-2NT, 2000-07-19



<PAGE>
                                                                  EXHIBIT 23.1


CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related prospectus of CV Therapeutics,
Inc. for the registration of a maximum of up to $120,000,000 of its common
stock and to the incorporation by reference therein of our report dated
March 2, 2000 with respect to the consolidated financial statements of CV
Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year
ended December 31, 1999, filed with the Securities and Exchange Commission.

                                                   /s/ ERNST & YOUNG LLP
                                                   --------------------------

Palo Alto, California
July 19, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission